GoldBamboo.com - Knowledge is strong medicine
  

Evaluation of Stool Tagging for Improved Patient Compliance - Article


  Not Signed In - Sign In / Register






Colon Polyps

Colonic Polyps; What I need to know about Colon Polyps


Clinical Trial: Evaluation of Stool Tagging for Improved Patient Compliance

This study is currently recruiting patients.
Verified by Center for Diagnostic Imaging July 2005

Sponsored by: Center for Diagnostic Imaging
Information provided by: Center for Diagnostic Imaging
ClinicalTrials.gov Identifier: NCT00124163

Purpose

CT Colonography has gained widespread multi-disciplinary interest as an evolving noninvasive colorectal screening examination, with the potential of improved patient compliance. Our prior work demonstrated that the bowel preparation was the least tolerable aspect of colorectal evalua-tion when compared to the CT Colonography and optical colonoscopy procedures. Stool tagging could provide a more gentle and efficient bowel preparation, with fewer false positives due to retained stool-mimicking polyps.

We hypothesize that image quality and patient preference will vary with stool tagging concentra-tion and dosing schedule. We propose to evaluate specific tool tagging protocols with the fol-lowing aims:

AIM 1: Perform a randomized trial of three specific stool tagging protocols using barium and iodine at CT Colonography in a well-characterized cohort of patients undergoing colorectal evaluation.

AIM 2: Analyze the CT Colonography and optical colonoscopy data to assess differences across stool tagging protocols for the outcome measures of patient preference, image quality in the pres-ence of tagging, and diagnostic reader performance.

We will use specific variations in stool tagging techniques to determine the best image quality of CT data (e.g., homogenous tagging of fluid and stool), and highest patient acceptability, as well as evaluate the adequacy of preparation for same-day colonoscopy. Diagnostic reader perform-ance will focus on the accuracy for detecting all neoplastic lesions including colon cancers, ade-nomatous polyps, sessile adenomas and flat adenomas. Most importantly, these results will help inform the design of a larger trial of an optimized CT Colonography technique in a community setting.

Condition Intervention Phase
Colon Cancer
Polyps
 Procedure: Imaging procedure of CT colonography
Phase I

MedlinePlus related topics:  Colorectal Cancer

Study Type: Observational
Study Design: Screening, Longitudinal, Random Sample, Prospective Study

Official Title: CT Colongraphy Ph. I CDI Trial: Evaluation of Stool Tagging for Improved Patient Compliance

Further Study Details: 

Expected Total Enrollment:  60

Study start: July 2005

CT Colonography, a rapidly evolving technique, offers a noninvasive and efficient colorectal screening examination, with the potential to improve patient compliance. However, currently it requires the bowel preparation, one of the largest barriers to colonoscopy screening. A promising new tool in CT Colonography is stool tagging, which has the potential to decrease the amount of catharsis required by patients during the bowel preparation, while decreasing the number of false positives due to the reader mistaking residual stool for polyps.

Our primary hypothesis is that image quality and patient compliance differ depending upon the tagging agent and dosing schedule. Our strategy is to vary key components of recently reported barium and iodine protocols to further optimize them and to compare our results with existing and currently aggregating data in collaboration with other investigators.

The following aims will implement this strategy:

AIM 1: Perform a randomized control trial of specific stool tagging protocols at CT Colonography in a well characterized cohort of patients undergoing colorectal evaluation.

Task 1A - Recruit a prospective cohort of 60 subjects, randomize them equally to three different stool tagging protocols, and sequentially perform CT Colonography and optical colonoscopy on them.

Task 1B - Assess image quality of CT Colonography and optical colonoscopy data by the method of bowel preparation in the first five subjects of each arm and implement specific changes, if necessary.

AIM 2: Analyze the CT Colonography and optical colonoscopy data to assess differences across study arms for the outcome measures of patient preference, image quality of tagged stool, and diagnostic reader performance.

Task 2A: Assess patient expectations regarding the bowel preparations, CT Colonogra-phy and colonoscopy before the procedures and their preferences after the procedures.

Task 2B: Evaluate image quality, in the presence of tagged stool and fluid, of both the CT data and the colonoscopy data.

Task 2C: Perform a multi-observer reader evaluation of diagnostic performance of CT Colonography and colonoscopy, compared to the enhanced reference standard of colono-scopy aided by segmental unblinding of CT results, to assess sensitivity and specificity of colorectal polyp detection.

Upon completion, the three specific variations in stool tagging techniques will be compared on homogenous density of tagging and patient acceptability to determine which protocol optimizes the trade-off. Diagnostic performance of CT and colonoscopy will be compared to the enhanced reference standard of colonoscopy aided by the segmental unblinding of CT results. Most sig-nificantly, these results may help determine an optimal tagging protocol to use for larger trials of CT Colonography implementation in community settings.

Eligibility

Ages Eligible for Study:  45 Years   -   80 Years,  Genders Eligible for Study:  Both

Accepts Healthy Volunteers

Criteria

Inclusion Criteria:Patients who are 45 to 80 years old for routine screening colonoscopy.

Exclusion Criteria:1) patients with inflammatory bowel disease, 2) patients with polyposis syndromes, 3) pregnant women, 4) patients over 350 pounds, 5) patients with bright red blood per rectum and 6) patients who have a contraindication to undergo outpatient colonoscopy, including patients on blood thinners, prior MI in the last six months, history of CHF, history of arrhythmia , patients too weak to transfer themselves from a bed to a chair, or patients with severe constipation who would require a two day bowel preparation.

All subjects will undergo informed consent by the St. Luke’s IRB. Referred subjects will be asked if they are interested in the study and those responding affirmatively will be transferred to a recruiter to learn about the study and begin the consent process if interested.

Location and Contact Information

Please refer to this study by ClinicalTrials.gov identifier  NCT00124163

Elizabeth G. McFarland, MD      636-733-8911    McFarlandB@mir.wustl.edu
Elisabeth Quam-Berne      952-525-6308    lquam@cdirad.com

Missouri
      Diagnostic Imaging Associates, Chesterfield,  Missouri,  63017,  United States; Recruiting
Elizabeth G. McFarland, MD  636-733-8911    McFarlandB@mir.wustl.edu 
Elisabeth Quam-Berne  952-525-6308    lquam@cdirad.com 
David Cort, MD,  Sub-Investigator
Gerry Lander, MD,  Sub-Investigator
Jay Marshall, MD,  Sub-Investigator
Todd Cunningham, MD,  Sub-Investigator

Study chairs or principal investigators

Elizabeth G. McFarland, MD,  Principal Investigator,  St. Luke''''s Hospital   

More Information

Publications

Pickhardt PJ, Choi JR, Hwang I, Butler JA, Puckett ML, Hildebrandt HA, Wong RK, Nugent PA, Mysliwiec PA, Schindler WR. Computed tomographic virtual colonoscopy to screen for colorectal neoplasia in asymptomatic adults. N Engl J Med. 2003 Dec 4;349(23):2191-200. Epub 2003 Dec 1.

Iannaccone R, Laghi A, Catalano C, Mangiapane F, Lamazza A, Schillaci A, Sinibaldi G, Murakami T, Sammartino P, Hori M, Piacentini F, Nofroni I, Stipa V, Passariello R. Computed tomographic colonography without cathartic preparation for the detection of colorectal polyps. Gastroenterology. 2004 Nov;127(5):1300-11.

Lefere PA, Gryspeerdt SS, Dewyspelaere J, Baekelandt M, Van Holsbeeck BG. Dietary fecal tagging as a cleansing method before CT colonography: initial results polyp detection and patient acceptance. Radiology. 2002 Aug;224(2):393-403.

Study ID Numbers:  633
Last Updated:  August 1, 2005
Record first received:  July 26, 2005
ClinicalTrials.gov Identifier:  NCT00124163
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2005-08-02


Take control over your directory listings...INSTANTLY

Every day, thousands of users find businesses like yours in the GoldBamboo directory.

Limited Time Offer!!!

For only $50 a year, a savings of 50% off our standard rate:

  • Edit your listing (whenever you want!)
  • Link to your website
  • Choose which categories you are listed in
  • Describe your services

The process will take only a few minutes and consists of 3 easy steps:

1. Register     >     2. Edit Listings     >     3. Publish

Your Company
your street
yourtown, YS 12345
888-888-8888



No Thanks

Popular Treatments

Acne Treatment ADHD Treatment Allergy Treatment Alzheimer's Treatment
Anemia Treatment Arthritis Treatment Asthma Treatment Bipolar Disorder Treatment
Bird Flu Treatment Bladder Cancer Treatment Bladder Control Treatment Blood Pressure Treatment
Brain Tumor Treatment Breast Cancer Treatment Bronchitis Treatment Cancer Treatment
Cancer Alternative Treatment Cataract Treatment Cirrhosis Treatment Colitis Treatment
Colon Cancer Treatment Common Cold Treatment Conjunctivitis Treatment Constipation Treatment
Crohn's Disease Treatment Cystic Fibrosis Treatment Depression Treatment Dermatitis Treatment
Diabetes Treatment Edema Treatment Epilepsy Treatment Erectile Dysfunction Treatment
Fibromyalgia Treatment GERD Treatment Glaucoma Treatment Gout Treatment
Hay Fever Treatment Headache Treatment Heart Disease Treatment Hepatitis Treatment
High Blood Pressure Treatment High Cholesterol Treatment Hives Treatment Hypertension Treatment
Hypoglycemia Treatment IBS Treatment Impotence Treatment Indigestion Treatment
Infertility Treatment Influenza Treatment Insomnia Treatment Lactose Intolerance Treatment
Leukemia Treatment Lung Cancer Treatment Lyme Disease Treatment Macular Degeneration Treatment
Menopause Treatment Migraine Treatment Osteoarthritis Treatment Osteoporosis Treatment
Pancreatic Cancer Treatment PMS Treatment Pneumonia Treatment Prostate Diseases Treatment
Restless Leg Treatment Rheumatoid Arthritis Treatment Sepsis Treatment Sinusitis Treatment
Skin Cancer Treatment Sleep Apnea Treatment Snoring Treatment Stroke Treatment
Testicular Cancer Treatment
GoldBambooTM

Your Integrative Health and Wellness Resource for Colon Polyps.

July 26, 2008



Page Updated: September 30, 2005
Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.

Insurance Quotes | Home | About Us | Link To Us | Feedback | Disclaimer | Privacy Policy | Terms of Use | Google Co-op | Health Forums

Copyright © 2004-2008 - Gold Bamboo LLC
All rights reserved.

HONcode accreditation seal.

We comply with the HONcode standard for health trust worthy information:
verify here.